To print: Select File and then Print from your browser's menu
Devices on the Market
All of the continuous glucose monitoring systems currently on the market measure glucose levels continuously and display glucose levels on a screen every five minutes. However, all must be calibrated with conventional blood glucose meter readings several times a day. They are approved for use in adults age 18 and older and require a prescription for purchase. The MiniMed Paradigm REAL-Time System and Guardian REAL-Time System are also available in pediatric models, approved for children ages 7–17.
Product: Seven System
The Seven System is composed of three separate elements—a sensor, a transmitter, and a receiver—that work together to provide real-time glucose measurements for up to seven days. The receiver can show glucose trends for 1-hour, 3-hour, and 9-hour periods. An alarm lets the user know if his glucose level is below 55 mg/dl, and the user can set optional alerts to let him know if his glucose level has risen or fallen outside of a target range that he defines.
The Seven System is not meant to replace traditional blood glucose monitoring and must be calibrated with two readings from a One-Touch Ultra blood glucose meter two hours after a new sensor is inserted and an additional reading at least every 12 hours thereafter.
Product: MiniMed Paradigm REAL-Time System
The system cannot automatically adjust the amount of insulin being delivered by the pump.
Two MiniMed pumps can be used with this system: the MiniMed Paradigm 522 insulin pump, which holds up to 176 units of insulin, and the MiniMed Paradigm 722 insulin pump, which holds up to 300 units of insulin.
Product: Guardian REAL-Time System
Statements and opinions expressed on this Web site are those of the authors and not necessarily those of the publishers or advertisers. The information provided on this Web site should not be construed as medical instruction. Consult appropriate health-care professionals before taking action based on this information.